Skip to main content
OpenTrials

Clinical trial condition

Spinocerebellar Ataxia 27B (SCA27B)

Explore clinical trials studying Spinocerebellar Ataxia 27B (SCA27B). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Spinocerebellar Ataxia 27B (SCA27B) trial results

Recruiting

A Randomized, Parallel-arm, Double Blind, Placebo-controlled Study to Assess the Efficacy of Fampridine for Patients With Spinocerebellar Ataxia SCA27B Caused by a GAA Expansion in the FGF14 Gene

NCT07185347

Conditions
Ataxia, Diplopia, Dyskinesias, +8 more
Locations
  • Neurology Department, CHU d'Angers Angers, France
  • Genetics Department, CHU de Bordeaux Bordeaux, France
  • Neurology and Gentics Department, CHU de Dijon Dijon, France
  • Neurology Department, Hôpital Pierre Wertheimer Hospital Lyon, France
View Trial Details

Related conditions